To the Editor:
Medical elastography consists of biomechanically characterising a zone of tissue on the basis of its response to the application of mechanical stress. This stress can be quasistatic (local compression) or vibratory (propagation of shear waves). In the various medical applications of elastography, the response to the stress is described by mapping the tensile modulus, or Young’s modulus. Young’s modulus corresponds to the slope of the stress–strain relationship measured during a series of tensile tests [1]. The elasticity of a tissue depends on its nature, its state (fat infiltration or fibrosis) and its homogeneity. A tumour situated in a zone of healthy tissue can, therefore, be detected by its decreased elasticity. The tumour can also be described in space, based on the principle that within anisotropic materials (typically represented by heterogeneous tissues), the value of Young’s modulus varies as a function of the direction of the force applied to the material tested. Simple colour coding of the tensile response provides mapping of the elasticity of the zone examined. Very hard tissues are generally coded as blue, while soft tissues are coded as red and intermediate tissues are coded as green.
Elastography is now used in various fields of medicine, often in combination with ultrasound (ultrasound elastography, sometimes called computer-assisted palpation). It has been applied to the diagnosis of breast [2], thyroid [3] and prostate tumours [4], in vascular disease [5], and in hepatology [6]. Elastography has also been combined with gastrointestinal endoscopic ultrasound to investigate pancreatic masses [7] and nodal invasion by rectal cancer [8]. A recent meta-analysis of the performances of gastrointestinal endoscopic ultrasound elastography to distinguish between benign and malignant lymph nodes concluded to a sensitivity of 88%, a specificity of 85% and an area under the receiver operating characteristics curve of 0.9456 [9]. These performances are superior to those of endoscopic ultrasound alone [10].
To our knowledge, elastography in combination with bronchial endoscopic ultrasound has not yet been evaluated. We report preliminary feasibility data and the first evaluation of this technique. This study was approved by the local ethics committee (Comité de Protection des Personnes Ile-de-France 6 Pitié-Salpêtrière, Paris, France).
All patients referred to our centre for assessment of mediastinal lymphadenopathy between February and May 2012 were studied by bronchial endoscopic ultrasound elastography under light general anaesthesia (10 patients, 13 lymph node areas measuring 10–30 mm). Real-time elastographic mapping was performed using an ultrasound elastography module incorporated into a ultrasound machine (Hi-vision Avius®; Hitachi Medical Systems, Kashiwa, Japan) coupled with a bronchial endoscopic ultrasound probe (EB1970 video bronchoscope; Pentax, Tokyo, Japan). Elasticity colour mapping was performed for each lymph node studied by superimposing the colour coding of tensile responses with the endoscopic B-mode ultrasound image and by defining the frequency histogram of the responses in the zone studied. Transbronchial needle aspiration (TBNA) was performed in each case using a 22-gauge needle (sono Tip® EBUS; MediGlobe, Rosenheim, Germany) by targeting, as far as possible, the zone identified as being the least elastic.
Colour mapping of the tissue studied and the corresponding elasticity histogram were obtained in every case (fig. 1). The elastography module proved easy to use and prolonged the examination time by only a few minutes. The five lymph nodes demonstrated to be malignant on histological examination of the TBNA material were characterised by decreased elasticity (dominant blue colour, elasticity ranging from 10 to 49 on the histogram and >80% of the tissue considered to be “hard” in the target zone) (table 1). No malignant cell was identified in the other eight lymph nodes (elasticity ranging from 55 to 167 and 6–71% hard zones) regardless of the final diagnosis. Although discussing specificity and sensitivity is not reasonably possible with such a small sample, these preliminary results are consistent with the results published for gastrointestinal endoscopic ultrasound [9, 10]. Notably, mediastinoscopy was not performed in those of our patients where TBNA did not provide diagnostic proof because a therapeutic decision was taken based on other factors (table 1). In future studies, the performances of endobronchial elastography will have to be assessed against the results of mediastinoscopy as the gold standard approach.
From this experience, we conclude that transbronchial biomechanical analysis can be performed during bronchial endoscopic ultrasound. Tracheobronchial cartilage does not appear to interfere with collection of this type of information. The preliminary results suggest that elastography could possibly improve the diagnostic yield of bronchial endoscopic ultrasound, as has already been demonstrated in gastrointestinal endoscopy. This is all the more important as endobronchial ultrasonography has a low negative predictive value regarding the neoplastic involvement of mediastinal lymph nodes (see [11] for an example). We propose that our preliminary results justify the setting-up of large-scale studies to precisely describe the operating characteristics of bronchial endoscopic ultrasound elastography. It would also be interesting to determine whether elastography could improve guidance of TBNA in heterogeneous lymph node masses or limit the number of TBNAs performed, by primarily targeting the lymph nodes most likely to be malignant.
Acknowledgments
The authors thank D. Khayat (Assistance Publique – Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Dept of Medical Oncology, Paris, France) and the “Association Pour la Vie – Espoir Contre le Cancer” (Paris) for their assistance in the acquisition of bronchial endoscopic ultrasound equipment by the Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Dept of Respiratory and Critical Care Medicine.
Footnotes
Support Statement
The “Association Pour la Vie – Espoir Contre le Cancer” provided financial support in the acquisition of bronchial endoscopic ultrasound equipment by the Groupe Hospitalier Pitié-Salpêtrière Charles Foix Dept of Respiratory and Critical Care Medicine (Paris, France).
Statement of Interest
None declared.
- ©ERS 2013